Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2020.12.16
2020年第四次临时股东大会的法律意见书
2020.12.10
H股公告
2020.12.05
关于开展远期外汇交易的可行性分析报告
2020.12.05
关于开展远期外汇交易的公告
2020.12.05
关于继续向中国邮政储蓄银行申请授信额度的公告
2020.12.05
关于调整中国进出口银行授信额度的公告
2020.12.05
关于延长员工持股计划存续期的公告
2020.12.05
第五届董事会第五次会议决议公告
2020.12.03
关于参加2020深圳辖区“诚实守信，做受尊重的上市公司”上市公司投资者网上集体接待日活动...
2020.11.24
H股公告
第一页
上一页
21
22
23
24
25
下一页
最后一页
